TABLE 3.

Multivariate Analysis of Factors Associated with OS

FactorHRPAdjusted HRAdjusted P
PDA vs. SDA0.51 (0.29–0.9)0.018
Resection after SIRT, yes vs. no0.17 (0.06–0.43)<10−30.15 (0.06–0.4)<10−3
Sex, female vs. male0.86 (0.27–2.77)0.797
Age, >65 y vs. ≤65 y1.13 (0.63–2)0.684
Child Pugh score, A6 or B7 vs. A51.61 (0.84–3.1)0.151
ECOG, 1 vs. 01.23 (0.69–2.19)0.471
Cirrhosis, yes vs. no2.4 (0.94–6.12)0.059
Multifocal vs. unifocal20.3 (1.13–3.65)0.016
Bilobar vs. unilobar2.1 (1.17–3.76)0.0112.33 (1.24–4.37)0.008
PVT, yes vs. no1.88 (0.98–3.63)0.054
Treatment line, subsequent vs. first1.09 (0.54–2.21)0.808
Index lesion size, ≥10 cm vs. <10 cm0.99 (0.56–1.76)0.968
AFP, ≥200 μg/L vs. <200 μg/L1.6 (0.91–2.83)0.098
Tumor involvement, ≥50% vs. <50%0.95 (0.29–3.07)0.927
TD, ≥205 Gy vs. <205 Gy0.42 (0.22–0.81)0.007
PLD, ≥150 Gy vs. <150 Gy0.42 (0.23–0.75)0.002
  • ECOG = Eastern Cooperative Oncology Group; AFP = α-fetoprotein.

  • Data in parentheses are 95% CIs.